March 15, 2019 10:23 AM EDT
News Briefing

Gen­fit read­ies its $120M IPO; Karyopharm shares boost­ed af­ter an FDA de­lay for se­linex­or

Natalie Grover

Reporter

→ Weeks af­ter of­fi­cial­ly un­veil­ing its plan to list on the Nas­daq, Lille-based liv­er drug de­vel­op­er Gen­fit on Thurs­day said it would of­fer 5 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

No­vo Nordisk is feel­ing the com­pe­ti­tion from com­pound­ed GLP-1s, ex­ec says

Ku­ra's AML drug pass­es key study in ad­vanced pa­tients, plans next steps with FDA and new­ly di­ag­nosed stud­ies

Am­gen an­nounces hold on Phase 1 obe­si­ty can­di­date, pipeline cuts

Small per­son­al­ized vac­cine tri­al sees progress in late-stage kid­ney can­cer

Pfiz­er says it has at least $10B avail­able for deals in 2025, with a fo­cus on pipeline

Bris­tol My­ers, Ky­owa Kirin dis­close lay­offs

A service from the Financial Times